summary
Introduced
05/14/2021
05/14/2021
In Committee
10/25/2022
10/25/2022
Crossed Over
06/20/2022
06/20/2022
Passed
10/27/2022
10/27/2022
Dead
Signed/Enacted/Adopted
11/03/2022
11/03/2022
Introduced Session
2021-2022 Regular Session
Bill Summary
Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for definitions.
AI Summary
This bill amends the definition of "drug paraphernalia" in the Controlled Substance, Drug, Device and Cosmetic Act to include fentanyl test strips. Fentanyl test strips are used to determine if a controlled substance contains dangerous compounds that can cause harm or death. The bill specifies that these testing products are not considered drug paraphernalia under the law. The bill takes effect 60 days after being enacted.
Committee Categories
Budget and Finance, Justice
Sponsors (28)
Jim Struzzi (R)*,
Aerion Abney (D),
Jessica Benham (D),
Karen Boback (R),
Tim Briggs (D),
Joe Ciresi (D),
Martell Covington (D),
Austin Davis (D),
Tina Davis (D),
Dan Deasy (D),
Dan Frankel (D),
Liz Hanbidge (D),
Carol Hill-Evans (D),
Stephen Kinsey (D),
Rick Krajewski (D),
Summer Lee (D),
Jeanne McNeill (D),
Dan Miller (D),
Nickolas Pisciottano (D),
F. Todd Polinchock (R),
Christopher Quinn (R),
Jim Rigby (R),
David Rowe (R),
Steve Samuelson (D),
Mike Schlossberg (D),
Melissa Shusterman (D),
Brian Smith (R),
Craig Williams (R),
Last Action
Act No. 111 of 2022 (on 11/03/2022)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...